Search


 
Results 1 - 10 of about 70 for "From ACP Journal Club".

In type 2 diabetes with CVD and kidney disease, empagliflozin ...

If the results are confirmed, sodium–glucose co-transporter-2 inhibitors will become a dominant strategy over standard glucose-lowering therapies for ...

In high-risk T1DM, real-time continuous glucose monitoring vs ...

The study provides compelling evidence for clinicians to recommend real-time continuous glucose monitoring to their patients at high risk for severe ...

Review compares effectiveness, cost, and safety of second ...

The review found that sulfonylureas were more cost-effective than newer agents, but an ACP Journal Club commentary stressed the importance of shared ...

In patients with type 2 diabetes and CV disease, empagliflozin ...

An industry-funded trial found that those who took empagliflozin had lower rates of mortality, including from cardiovascular (CV) events, than those on ...

Intensive weight management in primary care improved ...

The author of an ACP Journal Club commentary said that the intervention effect was strong enough to prompt a reconsideration of primary care management ...

Review: Adding a DPP-4 inhibitor to an SGLT-2 inhibitor ...

The authors of an accompanying ACP Journal Club commentary noted that although the risk for bias in the five reviewed studies was reportedly low, ...

Exenatide did not reduce major cardiovascular outcomes in ...

While exenatide can be considered a second-line option for patients with type 2 diabetes and some may prefer its once-weekly dosing, those at high ...

Review: In diabetes, intensive and standard glycemic control ...

The review suggests that treating diabetes with strict glycemic control does not reduce mortality or cardiovascular risk or slow progression of kidney disease ...

Self-monitoring of blood glucose did not improve HbA1c or ...

The randomized controlled trial adds to the evidence about routine use of self-monitoring of blood glucose for all patients with type 2 diabetes, according ...

In type 1 diabetes, education with either insulin pumps or daily ...

The results showed that when patients on multiple daily insulin injections received structured education, there was no additional benefit of switching ...

Result Page: 1 2 3 4 5  Next >